Jump to content

Drilldown: Medicines

Choose a table:


Medicines > duration: Daily dosing & halflife : 1-2 hours'"`UNIQ--ref-00000017-QINU`"' or Not formally established

Use the filters below to narrow your results.

generic:
None (1)
brand:
REL-1017 / esmethadone (investigational; not yet FDA-approved as of mid-2024) (1)
classes:
low-trapping) (1) · NMDA receptor antagonist (uncompetitive (1)
mechanism:
None (1)
uses:
Investigational for major depressive disorder; trials underway (phase 3 mixed results) (1)
starting dose:
Trials use 25 mg or 50 mg PO daily (1)
preparations:
Investigational oral capsule (1)
fda max:
Not yet approved (1)
routes:
Oral (1)
onset:
Rapid (within 1 week in trials) (1)
duration: (Click arrow to add another value)
halflife: (Click arrow to add another value)
bioavailability:
Oral bioavailability suitable for daily dosing (1)
pregnancy:
Investigational (1)
legal:
Investigational (1)
Error in "where" parameter: the string "--" cannot be used within #cargo_query.

There are no results for this report.

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"